Safety issues with cyclosporine

International Journal of Dermatology

Volumn 36, Issue SUPPL. 1, 1997, Pages 7-10

  Ellis, Charles N ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYCLOSPORIN A; FISH OIL; IMMUNOSUPPRESSIVE AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

CANCER; CLINICAL TRIAL; CONFERENCE PAPER; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTIOUS COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PRACTICE GUIDELINE; PSORIASIS; SKIN DISEASE; SKIN TOXICITY;

EID: 0031445801     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.36.s1.3.x     Document Type: Conference Paper

References (11)

1. Ellis CN, Fradin MS, Messana JM, et al. Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N Engl J Med 1991; 324: 277-284.
2. Powles AV, Carmichael D, Hulme B, et al. Renal function after long-term low-dose cyclosporin for psoriasis. Br J Dermatol 1990; 122: 665-669.
3. Messana JM, Rocher LL, Ellis CN, et al. Effects of cyclosporine on renal function in psoriasis patients. J Am Acad Dermatol 1990; 23: 1288-1293.
4. Feutren G, Mihatsch MG. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992; 326: 1654-1660.
5. Mihatsch MJ, Wolff K. Consensus conference on cyclosporine A for psoriasis, February 1992. Br J Dermatol 1992; 126: 621-623.
6. Zachariae H, Hansen HE, Kragballe K, et al. Morphologic renal changes during cyclosporine treatment of psoriasis. J Am Acad Dermatol 1992; 26: 415-419.
7. Young EW, Ellis CN, Messana JM, et al. A prospective study of renal structure and function in psoriasis patients treated with cyclosporine. Kidney Int 1994; 46: 1216-1222.
8. Homan van der Heide JJ, Bilo HJ, Donker JM, et al. Effect of dietary fish oil on renal function and rejection in cyclosporine-recipients of renal transplants. N Engl J Med 1993; 329: 769-773.
9. Stoof TH, Korstanje MJ, Bilo HF, et al. Does fish oil protect renal function in cyclosporine-treated psoriasis patients? J Intern Med 1989; 226: 437-441.
10. Fradin MS, Ellis CN, Voorhees JJ. Management of patients and side effects during cyclosporine therapy for cutaneous disorders. J Am Acad Dermatol 1990; 23: 1265-1275.
11. Gupta AK, Cooper KD, Ellis CN, et al. Lymphocytic infiltrates of the skin in association with cyclosporine therapy. J Am Acad Dermatol 1990; 23: 1137-1141.